242 related articles for article (PubMed ID: 15317601)
1. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes.
Daousi C; MacFarlane IA; Woodward A; Nurmikko TJ; Bundred PE; Benbow SJ
Diabet Med; 2004 Sep; 21(9):976-82. PubMed ID: 15317601
[TBL] [Abstract][Full Text] [Related]
2. The natural history of chronic painful peripheral neuropathy in a community diabetes population.
Daousi C; Benbow SJ; Woodward A; MacFarlane IA
Diabet Med; 2006 Sep; 23(9):1021-4. PubMed ID: 16922710
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia.
Halawa MR; Karawagh A; Zeidan A; Mahmoud AE; Sakr M; Hegazy A
Curr Med Res Opin; 2010 Feb; 26(2):337-43. PubMed ID: 19968592
[TBL] [Abstract][Full Text] [Related]
4. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.
Kadiroglu AK; Sit D; Kayabasi H; Tuzcu AK; Tasdemir N; Yilmaz ME
J Diabetes Complications; 2008; 22(4):241-5. PubMed ID: 18413214
[TBL] [Abstract][Full Text] [Related]
5. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns.
Tölle T; Xu X; Sadosky AB
J Diabetes Complications; 2006; 20(1):26-33. PubMed ID: 16389164
[TBL] [Abstract][Full Text] [Related]
6. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.
Davies M; Brophy S; Williams R; Taylor A
Diabetes Care; 2006 Jul; 29(7):1518-22. PubMed ID: 16801572
[TBL] [Abstract][Full Text] [Related]
7. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors.
Janghorbani M; Rezvanian H; Kachooei A; Ghorbani A; Chitsaz A; Izadi F; Amini M
Acta Neurol Scand; 2006 Dec; 114(6):384-91. PubMed ID: 17083338
[TBL] [Abstract][Full Text] [Related]
8. Sleep impairment in patients with painful diabetic peripheral neuropathy.
Zelman DC; Brandenburg NA; Gore M
Clin J Pain; 2006 Oct; 22(8):681-5. PubMed ID: 16988563
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of diabetic peripheral neuropathy in an outpatient setting.
Mimi O; Teng CL; Chia YC
Med J Malaysia; 2003 Oct; 58(4):533-8. PubMed ID: 15190629
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, interference, and risk factors for chronic pain among Taiwanese community older people.
Yu HY; Tang FI; Kuo BI; Yu S
Pain Manag Nurs; 2006 Mar; 7(1):2-11. PubMed ID: 16490731
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
12. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy.
Daousi C; Benbow SJ; MacFarlane IA
Diabet Med; 2005 Apr; 22(4):393-8. PubMed ID: 15787662
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55).
Pradeepa R; Rema M; Vignesh J; Deepa M; Deepa R; Mohan V
Diabet Med; 2008 Apr; 25(4):407-12. PubMed ID: 18294224
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
Van Acker K; Bouhassira D; De Bacquer D; Weiss S; Matthys K; Raemen H; Mathieu C; Colin IM
Diabetes Metab; 2009 Jun; 35(3):206-13. PubMed ID: 19297223
[TBL] [Abstract][Full Text] [Related]
15. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.
Zelman DC; Gore M; Dukes E; Tai KS; Brandenburg N
J Pain Symptom Manage; 2005 Apr; 29(4):401-10. PubMed ID: 15857744
[TBL] [Abstract][Full Text] [Related]
16. Predictors of depression in Chinese community-dwelling people with type 2 diabetes.
Yang J; Li S; Zheng Y
J Clin Nurs; 2009 May; 18(9):1295-304. PubMed ID: 19413557
[TBL] [Abstract][Full Text] [Related]
17. Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East.
Hoffman DL; Sadosky A; Alvir J
Pain Pract; 2009; 9(1):35-42. PubMed ID: 19019046
[TBL] [Abstract][Full Text] [Related]
18. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2.
Raman R; Rani PK; Reddi Rachepalle S; Gnanamoorthy P; Uthra S; Kumaramanickavel G; Sharma T
Ophthalmology; 2009 Feb; 116(2):311-8. PubMed ID: 19084275
[TBL] [Abstract][Full Text] [Related]
20. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
